340B Recertification for CDC Grantees Starts May 8

Recertification
Annual 340B recertification for CDC grantees will be May 8 through June 5.

This year’s annual 340B recertification period for U.S. Centers for Disease Prevention and Control grantees—Title X family planning, sexually transmitted disease, and tuberculosis clinics—will be May 8 through June 5, the U.S. Health Resources and Services Administration said Tuesday.

Recertification

Read More »

Expert Tip From The Craneware Group

img
img

TIP: Don’t forget that in a replenishment model, 340B purchases are primarily made after determining eligibility through accumulated eligibility.


Read More »

In Surprise Move, Pennsylvania Wants 340B Modifiers on Medicaid Managed Care Drugs

Pennsylvania
Pennsylvania 340B covered entities say they were blindsided by the state's disclosure last week that it wants drug claims billed to Medicaid managed care organizations to include a modifier showing if the prescription was filled with a 340B-purchased drug.

Pennsylvania health centers are upset about what they say was the state Medicaid office’s disclosure without warning last week that, starting July 1, it wants drug claims billed to Medicaid managed care organizations to include a modifier showing if the

Read More »

Iowa Set to Enact Nation’s 25th 340B Nondiscrimination Law

Iowa state capitol
The Iowa Senate last week passed a 340B nondiscrimination bill 49-1, sending it to Gov. Kim Reynolds. The House passed it earlier 98-0.

The Iowa Senate last week passed a House-approved bill banning pharmacy benefit manager and payor discrimination against 340B covered entities and their contract pharmacies, including reimbursing the entities at a lower rate than non-340B providers.

The Senate voted 49-1 on

Read More »

Daiichi-Sankyo Offering Refunds for 340B Overcharges on Two Drugs

Enhertu
Daiichi-Sankyo is offering refunds for 340B overcharges on its breast cancer drug Enhertu and cholesterol drug Welchol for Oral Suspension.

Drug manufacturer Daiichi-Sankyo is offering 340B covered entities refunds for overcharges on metastatic breast cancer treatment Enhertu during Q1 2020 and on cholesterol medication Welchol for Oral Suspension during Q1 2022 and Q4 2022.

The U.S. Health Resources and Services

Read More »

340B PROVIDER LEADER SPOTLIGHT

Fatimah Muhammad, Director, 340B Pharmaceutical Svcs & Drug Replacement, Saint Peter’s University Hospital

Fatimah Muhammad

Q: If a friend came to visit you in your hometown, where would you take them? Where would you take them in your state?

Hometown: I would take

Read More »

New 340B Transparency Bill to be Discussed Next Week in House Hearing, U.S. Senate Bills Introduced

Bucshon bill
Rep. Larry Bucshon (R-Ind.) has has written a bill to impose significant 340B program reporting requirements on disproportionate share hospitals and maybe other covered entities.

U.S. Rep. Larry Bucshon (R-Ind.), vice chair of the House Energy & Commerce health subcommittee, has written a bill to impose significant 340B program reporting requirements on disproportionate share hospitals and potentially other covered entities. Meanwhile, two bills have been

Read More »

HRSA Administrator Open to Congress’ Help Ensuring 340B Accountability and Transparency

Carole Johnson
HRSA Administrator Carole Johnson said during a House hearing yesterday she would welcome congressional help ensuring there is “accountability and transparency” in 340B.

U.S. Health Resources and Services Administration Administrator Carole Johnson said on Capitol Hill yesterday that HRSA would welcome congressional help ensuring there is “accountability and transparency” in the 340B program.

Johnson was answering questions from Rep. Morgan Griffith (R-Va.) during

Read More »

Hospitals Urge Fed. Appeals Court to Uphold Novel Ark. Law Protecting 340B Discounts in Contract Pharmacy Setting

Eighth Circuit Court
PhRMA filed a citation to notify the U.S. Eighth Circuit Court of Appeals in St. Louis that Arkansas is enforcing its 340B contract pharmacy law.

Three groups representing 340B hospitals late last week filed an amicus brief in federal circuit court in support of Arkansas’ novel contract pharmacy law, arguing the law doesn’t conflict with the 340B statute and in fact furthers the goals of

Read More »

Closed Pennsylvania 340B Hospital Sues CVS Health Over 340B TPA Policy

Brandywine Hospital
A closed Pennsylvania hospital has filed a federal antitrust class action against CVS over its 340B contract pharmacy policies.

A Philadelphia-area hospital that closed last year after its sale fell through has filed a federal antitrust class action against healthcare conglomerate CVS over its 340B contract pharmacy policies.

The same shuttered hospital has been challenging in state court its

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live